{{Rsnum
|rsid=1543922
|Gene=ZNF175
|Chromosome=19
|position=51581583
|Orientation=plus
|GMAF=0.1272
|Gene_s=ZNF175
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 100.0 | 0.0 | 0.0
| HCB | 78.8 | 21.2 | 0.0
| JPT | 70.8 | 26.5 | 2.7
| YRI | 36.1 | 48.3 | 15.6
| ASW | 49.1 | 42.1 | 8.8
| CHB | 78.8 | 21.2 | 0.0
| CHD | 78.9 | 18.3 | 2.8
| GIH | 95.0 | 5.0 | 0.0
| LWK | 48.2 | 42.7 | 9.1
| MEX | 77.6 | 22.4 | 0.0
| MKK | 64.1 | 28.2 | 7.7
| TSI | 99.0 | 1.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22491018
|Trait=None
|Title=Genome-wide association analysis implicates the involvement of eight loci with response to tocilizumab for the treatment of rheumatoid arthritis.
|RiskAllele=
|Pval=3E-7
|OR=34.4800
|ORtxt=None
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}